Here's Why Hold Strategy is Apt for Xylem Stock Right Now

Xylem (XYL) is currently rated a Hold, benefiting from strong demand in its Measurement & Control Solutions and Water Infrastructure segments, with a Q1 2025 backlog of $5.1 billion and projected 2025 revenue growth of 1-2%. Acquisitions like Evoqua and Idrica are bolstering capabilities and revenue, yet a significant $1.97 billion debt and rising operating costs are pressuring margins, despite recent dividend increases and share repurchases.

Analysis

Xylem Inc. (XYL) demonstrates positive momentum driven by strong demand in its Measurement & Control Solutions segment, particularly for smart metering, and strength in the Water Infrastructure segment due to increased U.S. infrastructure projects. The Applied Water segment is also recovering, supported by higher demand for building solutions. This demand is reflected in a substantial backlog of $5.1 billion at the end of Q1 2025. For 2025, Xylem projects revenues between $8.7 billion and $8.8 billion, representing a 1-2% year-over-year increase. Strategic acquisitions are key to Xylem's growth strategy; the December 2024 acquisition of Idrica is expected to enhance technological capabilities and market penetration, while the May 2023 buyout of Evoqua contributed $786 million to 2024 revenues and complements Xylem's water cycle solutions. Xylem is also committed to shareholder returns, evidenced by $98 million in dividends paid and $12.9 million in shares repurchased in Q1 2025, alongside an 11% dividend rate hike in February 2025. The stock has outperformed its industry in the past month, gaining 4% versus the industry's 1.9%. However, significant challenges persist, including a high long-term debt of $1.97 billion against cash and cash equivalents of $1.06 billion as of Q1 2025. Escalating operating costs are also a concern, with the cost of revenues increasing 1.6% in Q1 2025 after a 15.1% surge in 2024, and selling, general, and administrative expenses rising 8.8% in 2024, partly due to Evoqua's integration. These factors contribute to its Zacks Rank #3 (Hold) status.

Key Decisions for Investors

• Investors should consider Xylem's solid demand drivers and $5.1 billion backlog against its considerable $1.97 billion debt and escalating operating costs when evaluating their position.
• Closely monitor the financial impact and synergistic benefits from the Idrica and Evoqua acquisitions, particularly their contribution to mitigating margin pressures from rising costs and debt service.
• While the 11% dividend increase and ongoing share repurchases are attractive, assess their sustainability in light of the company's modest 1-2% projected revenue growth for 2025 and existing financial leverage.